SCHEMBL11265822

SCHEMBL11265822

CC(=O)OCCCCOC(=O)c1cc(Br)c(N)c(CNC(C)C)c1.Clc1cccc(Cl)c1Nc1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.34
▸ CA12 O43570 3/20 0.34
▸ CA1 P00915 3/20 0.34
▸ CA2 P00918 3/20 0.34
▸ CA4 P22748 3/20 0.34
▸ CA9 Q16790 3/20 0.34
▸ CA3 P07451 2/20 0.34
▸ CA6 P23280 2/20 0.34
▸ CA5A P35218 2/20 0.34
▸ CA7 P43166 2/20 0.34
▸ CA13 Q8N1Q1 2/20 0.34
▸ CA14 Q9ULX7 2/20 0.34
▸ CA5B Q9Y2D0 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ CXCL8 P10145 1/20 0.32
▸ ADRB2 P07550 3/20 0.32
▸ ADRB1 P08588 3/20 0.32
▸ ADRB3 P13945 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11259600 0.99 NPSR1 (0.34) NPSR1CA12CA1CA2CA4
SCHEMBL11271891 0.87 HTT (0.36) SMN1; SMN2TP53MAPTTDP1ALDH1A1
SCHEMBL11268609 0.87 MAPT (0.35) CA12CA1CA2CA4CA9
SCHEMBL11259321 0.86 HTT (0.35) SMN1; SMN2TP53MAPTTDP1ALDH1A1
SCHEMBL11261972 0.86 TP53 (0.35) CA12CA1CA2CA4CA9
SCHEMBL11266856 0.85 SLC29A1 (0.40) NPSR1ALDH1A1BCHEMEN1KMT2A
SCHEMBL11271896 0.85 TP53 (0.38) CA12CA1CA2CA4CA9
SCHEMBL11258128 0.85 SLC29A1 (0.40) ALDH1A1BCHEMEN1KMT2ACYP2D6
SCHEMBL11261658 0.85 TP53 (0.37) CA12CA1CA2CA4CA9
SCHEMBL11271775 0.85 TP53 (0.37) CA12CA1CA2CA4CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4362738-A ANTIINFLAMMATORIES DR. KARL THOMAE GMBH (DE) 1982-12-07 — — US disclosed
Send feedback